Epithelial Ovarian Carcinoma Clinical Trial
Official title:
A Randomized, Open-label, Parallel Group, Multi-center Phase II Clinical Trial Evaluating Effect of Addition of DCVAC/OvCa to Standard Chemotherapy in Women With Relapsed Platinum (Pt)-Resistant Epithelial Ovarian Carcinoma
The purpose of this study is to determine whether DCVAC/OvCa added to chemotherapy may result in prolongation of Overall Survival (OS).
The purpose of this study is to determine whether DCVAC/OvCa added to Standard of Care chemotherapy may result in prolongation of Overall Survival (OS). ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05059444 -
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
|
||
| Recruiting |
NCT00349505 -
Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
|
Phase 2 | |
| Recruiting |
NCT05470920 -
Genetic Testing Decision Aid
|
N/A | |
| Recruiting |
NCT02611024 -
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT01138137 -
N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
|
Phase 1 | |
| Recruiting |
NCT02437812 -
Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma
|
Phase 2 | |
| Recruiting |
NCT02344095 -
A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer
|
Phase 1 | |
| Recruiting |
NCT05086692 -
A Beta-only IL-2 ImmunoTherapY Study
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04834544 -
A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care
|
Phase 2 |